Dr. Crawford on Abiraterone Versus Enzalutamide in Prostate Cancer

Dr. Crawford on Abiraterone Versus Enzalutamide in Prostate Cancer

E. David Crawford, MD, professor of Radiation Oncology, Department of Surgery, University of Colorado Denver, discusses factors in selecting treatment with abiraterone acetate (Zytiga) versus enzalutamide (Xtandi) for patients with castration-resistant …

(Visited 6 times, 1 visits today)
4
Like
Save

Comments

Comments are disabled for this post.